These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7139191)
1. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate. Cusack NJ; Hourani SM Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191 [TBL] [Abstract][Full Text] [Related]
2. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets. Hall DA; Hourani SM Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360 [TBL] [Abstract][Full Text] [Related]
3. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Cusack NJ; Hourani SM Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375 [TBL] [Abstract][Full Text] [Related]
4. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429 [TBL] [Abstract][Full Text] [Related]
5. Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets. Cusack NJ; Hourani SM Br J Pharmacol; 1981 Jun; 73(2):409-12. PubMed ID: 7236993 [TBL] [Abstract][Full Text] [Related]
6. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. Macfarlane DE; Srivastava PC; Mills DC J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277 [TBL] [Abstract][Full Text] [Related]
7. Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate. Cusack NJ; Hourani SM Br J Pharmacol; 1982 Feb; 75(2):397-400. PubMed ID: 7186826 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets. Park HS; Hourani SM Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285 [TBL] [Abstract][Full Text] [Related]
9. Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate). Cusack NJ; Hourani SM Br J Pharmacol; 1982 Feb; 75(2):257-9. PubMed ID: 6892270 [TBL] [Abstract][Full Text] [Related]
10. Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets. Cusack NJ; Hourani SM Br J Pharmacol; 1981 Jun; 73(2):405-8. PubMed ID: 7236992 [TBL] [Abstract][Full Text] [Related]
11. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets. Hall DA; Hourani SM Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900 [TBL] [Abstract][Full Text] [Related]
12. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase. Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276 [TBL] [Abstract][Full Text] [Related]
13. Identification of a receptor for ADP on blood platelets by photoaffinity labelling. Cristalli G; Mills DC Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):875-81. PubMed ID: 8387782 [TBL] [Abstract][Full Text] [Related]
14. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834 [TBL] [Abstract][Full Text] [Related]
15. Inhibition by a stable analogue of adenosine triphosphate of platelet aggregation by adenosine diphosphate. Born GV; Foulks JG Br J Pharmacol; 1977 Sep; 61(1):87-9. PubMed ID: 912211 [TBL] [Abstract][Full Text] [Related]
16. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate. Hourani SM; Hall DA; Nieman CJ Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134 [TBL] [Abstract][Full Text] [Related]
17. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate. Pearce PH; Wright JM; Egan CM; Scrutton MC Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037 [TBL] [Abstract][Full Text] [Related]
18. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase. Macfarlane DE; Mills DC; Srivastava PC Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146 [No Abstract] [Full Text] [Related]
19. Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5'-diphosphate. Hall DA; Frost V; Hourani SM Biochem Pharmacol; 1994 Oct; 48(7):1319-26. PubMed ID: 7945429 [TBL] [Abstract][Full Text] [Related]
20. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors. Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]